Bioorganic & Medicinal Chemistry Letters 2007-01-01

Intermediate analogue inhibitors of mandelate racemase: N-Hydroxyformanilide and cupferron.

Jennifer R Bourque, Rodney K M Burley, Stephen L Bearne

Index: Bioorg. Med. Chem. Lett. 17 , 105-8, (2007)

Full Text: HTML

Abstract

Mandelate racemase (MR) catalyzes the 1,1-proton transfer that interconverts the enantiomers of mandelate. The transition state/intermediate analogues N-hydroxyformanilide (K(i)=2.79+/-0.19 microM) and cupferron (K(i)=2.67+/-0.09 microM) are identified as potent competitive inhibitors of MR. The pH-pK(i) profile indicates that MR can bind either the protonated or deprotonated forms of N-hydroxyformanilide, with a 10-fold greater affinity for the latter form.


Related Compounds

Related Articles:

Simultaneous determination of aromatic acid metabolites of styrene and styrene-oxide in rat urine by gas chromatography-flame ionization detection.

2012-06-01

[J. Anal. Toxicol. 36(5) , 312-8, (2012)]

Chiral separation of D,L-mandelic acid through cellulose membranes.

2011-05-01

[Chirality 23(5) , 379-82, (2011)]

DNA damage and susceptibility assessment in industrial workers exposed to styrene.

2012-01-01

[J. Toxicol. Environ. Health A 75(13-15) , 735-46, (2012)]

A chiral bisthiourea as a chiral solvating agent for carboxylic acids in the presence of DMAP.

2013-09-20

[J. Org. Chem. 78(18) , 9137-42, (2013)]

Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen.

2013-01-01

[Journal. of. Drugs in. Dermatology. 12(1) , 45-50, (2013)]

More Articles...